Low-Dose Nivolumab with or without Ipilimumab as Adjuvant Therapy Following the Resection of Melanoma Metastases: A Sequential Dual Cohort Phase II Clinical Trial
低剂量 Nivolumab 联合或不联合 Ipilimumab 作为黑色素瘤转移切除术后的辅助治疗:一项序贯双队列 II 期临床试验
期刊:Cancers
影响因子:
doi:10.3390/cancers14030682
Julia Katharina Schwarze, Soizic Garaud, Yanina J L Jansen, Gil Awada, Valérie Vandersleyen, Jens Tijtgat, Alexandre de Wind, Paulus Kristanto, Teofila Seremet, Karen Willard-Gallo, Bart Neyns